Improved HIV vaccine candidates activating naïve B- cells expressing germline bNAb precursors
Improved HIV vaccine candidates activating naïve B- cells expressing germline bNAb precursors – Licensing opportunity (PDF)
Explore other Stories:
AI voor veiligheid, zorg en welbevinden
AI voor veiligheid, zorg en welbevinden Contactpersoon: Dhr. prof. dr. C.G.M. (Cees) Snoek, Universiteit van Amsterdam
Entrepreneurship Education
Developing high-quality entrepreneurship education – Amsterdam’s higher education institutions have been working closely together on this since 2008. This was done in the IXAnext valorisation program between 2016 and 2021. We proudly present the main results of the IXAnext program: Ten Amsterdam entrepreneurship cases; Post experience education for alumni; Blended learning modules; A mentoring platform […]
Developing a product of clinical value takes time
With their user-friendly measurement instrument for the quantification of spasticity, Jules Becher and Jaap Harlaar aim to revolutionise therapy in children with spasticity. Becher explains that the cause of spastic muscles can be of neurophysiological or biomechanical origin, each requiring specific therapy. By employing three different sensors the new device can pinpoint the precise cause […]